Homebiopharmaceutical

biopharmaceutical

Biotech

CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15

December 8, 2020

Biotech

Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference

December 7, 2020

Biotech

Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

December 7, 2020

Biotech

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020

December 7, 2020

$Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma$

Biotech

Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma

December 7, 2020

Biotech

Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz® in Scandinavia

December 7, 2020

Biotech

Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin

December 7, 2020

Biotech

Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis

December 7, 2020

Biotech

Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition

December 7, 2020

Biotech

Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference

December 7, 2020

« 1 … 552 553 554 555 556 … 558 »

SEARCH FOR AN ARTICLE

biopharmaceutical

CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15

Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference

Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2020

Affimed Announces Updated AFM13 Clinical Data Presentation at the American Society of Hematology Annual Meeting, Demonstrating Good Tolerability and a High Objective Response Rate in Patients with Recurrent/Refractory CD30-positive Lymphoma

Biofrontera enters into a license and supply agreement with Galenica AB for the marketing of Ameluz® in Scandinavia

Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin

Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis

Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell Function at the 2020 American Society of Hematology Annual Meeting and Exposition

Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference

LATEST NEWS